Announcement of the Advisory Panel on Outreach and Education (APOE) June 25, 2020 Meeting, 35655-35657 [2020-12653]
Download as PDF
<![CDATA[
jbell on DSKJLSW7X2PROD with NOTICES
Federal Register / Vol. 85, No. 113 / Thursday, June 11, 2020 / Notices
Administration’s commitment to
improving service delivery. By
qualitative feedback we mean
information that provides useful
insights on perceptions and opinions,
but are not statistical surveys that yield
quantitative results that can be
generalized to the population of study.
This feedback will provide insights into
customer or stakeholder perceptions,
experiences and expectations, provide
an early warning of issues with service,
or focus attention on areas where
communication, training or changes in
operations might improve delivery of
products or services. These collections
will allow for ongoing, collaborative and
actionable communications between the
Agency and its customers and
stakeholders. It will also allow feedback
to contribute directly to the
improvement of program management.
The current clearance was approved on
November 3, 2017 (OMB Control
Number 0935–0179) and will expire on
November 30, 2020.
Feedback collected under this generic
clearance will provide useful
information, but it will not yield data
that can be generalized to the overall
population. This type of generic
clearance for qualitative information
will not be used for quantitative
information collections that are
designed to yield reliably actionable
results, such as monitoring trends over
time or documenting program
performance. Such data uses require
more rigorous designs that address: The
target population to which
generalizations will be made, the
sampling frame, the sample design
(including stratification and clustering),
the precision requirements or power
calculations that justify the proposed
sample size, the expected response rate,
methods for assessing potential nonresponse bias, the protocols for data
collection, and any testing procedures
that were or will be undertaken prior to
fielding the study. Depending on the
degree of influence the results are likely
to have, such collections may still be
eligible for submission for other generic
mechanisms that are designed to yield
quantitative results.
Below we provide AHRQ’s projected
average annual estimates for the next
three years:
Current Actions: New collection of
information.
Type of Review: New Collection.
Affected Public: Individuals and
Households, Businesses and
Organizations, State, Local or Tribal
Government.
Average Expected Annual Number of
Activities: 10.
Respondents: 10,900.
VerDate Sep<11>2014
17:33 Jun 10, 2020
Jkt 250001
Annual responses: 10,900.
Frequency of Response: Once per
request.
The total number of respondents
across all 10 activities in a given year is
10,900.
Average minutes per response: 19.
Burden hours: 3,383.
An agency may not conduct or
sponsor, and a person is not required to
respond to, a collection of information
unless it displays a currently valid
Office of Management and Budget
control number.
Request for Comments
In accordance with the Paperwork
Reduction Act, comments on AHRQ’s
information collection are requested
with regard to any of the following: (a)
Whether the proposed collection of
information is necessary for the proper
performance of AHRQ healthcare
research and healthcare information
dissemination functions, including
whether the information will have
practical utility; (b) the accuracy of
AHRQ’s estimate of burden (including
hours and costs) of the proposed
collection(s) of information; (c) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(d) ways to minimize the burden of the
collection of information upon the
respondents, including the use of
automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
comments will become a matter of
public record.
35655
Firearm-Related Violence and Injuries;
July 6–10, 2020, 8:30 a.m.–5:00 p.m.,
EDT, Videoconference which was
published in the Federal Register on
June 1, 2020, Volume 85, Number 105,
page 33159. The meeting is being
amended to include specific dates and
times of the panels. CE20–006: Research
Grants to Prevent Firearm-Related
Violence and Injuries—Panel A will be
held July 6–7, 2020 from 8:30 a.m.–5:00
p.m., EDT. CE20–006: Research Grants
to Prevent Firearm-Related Violence and
Injuries—Panel B1 and Panel B2 will be
held July 8–10, 2020 from 8:30 a.m.–
5:00 p.m., EDT. The meeting is closed
to the public.
FOR FURTHER INFORMATION CONTACT:
Mikel Walters, Ph.D., Scientific Review
Official, National Center for Injury
Prevention and Control, CDC, 4770
Buford Highway NE, Mailstop F–63,
Atlanta, Georgia 30341, Telephone (404)
639–0913, MWalters@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2020–12654 Filed 6–10–20; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: June 5, 2020.
Virginia L. Mackay-Smith,
Associate Director.
[FR Doc. 2020–12582 Filed 6–10–20; 8:45 am]
BILLING CODE 4160–90–P
Centers for Medicare & Medicaid
Services
[CMS–7058–N]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Announcement of the Advisory Panel
on Outreach and Education (APOE)
June 25, 2020 Meeting
Centers for Disease Control and
Prevention
AGENCY:
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP)—CE20–006:
Research Grants To Prevent FirearmRelated Violence and Injuries;
Amended Notice of Meeting
Notice is hereby given of a change in
the meeting of the Disease, Disability,
and Injury Prevention and Control
Special Emphasis Panel (SEP)—CE20–
006: Research Grants to Prevent
PO 00000
Frm 00023
Fmt 4703
Sfmt 4703
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice.
This notice announces the
next meeting of the APOE (the Panel) in
accordance with the Federal Advisory
Committee Act. The Panel advises and
makes recommendations to the
Secretary of the U.S. Department of
Health and Human Services (HHS) and
the Administrator of the Centers for
Medicare & Medicaid Services (CMS) on
opportunities to enhance the
SUMMARY:
E:\FR\FM\11JNN1.SGM
11JNN1
35656
Federal Register / Vol. 85, No. 113 / Thursday, June 11, 2020 / Notices
effectiveness of consumer education
strategies concerning the Health
Insurance Marketplace, Medicare,
Medicaid, and the Children’s Health
Insurance Program (CHIP). This meeting
is open to the public.
DATES:
Meeting Date: Thursday, June 25,
2020, 12:30 p.m. to 4:45 p.m. eastern
daylight time (e.d.t).
Deadline for Meeting Registration,
Presentations, Special Accommodations
and Comments: Wednesday, June 17,
2020, 5:00 p.m. eastern daylight time
(e.d.t).
ADDRESSES:
Meeting Location: The meeting will be
held virtually. All those who RSVP will
receive the link to attend.
Presentations and Written Comments:
Presentations and written comments
should be submitted to: Lisa Carr,
Designated Federal Official (DFO),
Office of Communications, Centers for
Medicare & Medicaid Services, 200
Independence Avenue SW, Mailstop
325G HHH, Washington, DC 20201,
202–690–5742, or via email at APOE@
cms.hhs.gov.
Registration: The meeting is open to
the public, but attendance is limited to
the space available. Persons wishing to
attend this meeting must register at the
website https://www.eventbrite.com/e/
104529556718/ or by contacting the
DFO listed in the FOR FURTHER
INFORMATION CONTACT section of this
notice, by the date listed in the DATES
section of this notice. Individuals
requiring sign language interpretation or
other special accommodations should
contact the DFO at the address listed in
the ADDRESSES section of this notice by
the date listed in the DATES section of
this notice.
FOR FURTHER INFORMATION CONTACT: Lisa
Carr, Designated Federal Official, Office
of Communications, 200 Independence
Avenue SW, Mailstop 325G HHH,
Washington, DC 20201, 202–690–5742,
or via email at APOE@cms.hhs.gov.
Additional information about the APOE
is available at: https://www.cms.gov/
Regulations-and-Guidance/Guidance/
FACA/APOE. Press inquiries are
handled through the CMS Press Office
at (202) 690–6145.
SUPPLEMENTARY INFORMATION:
jbell on DSKJLSW7X2PROD with NOTICES
I. Background and Charter Renewal
Information
A. Background
The Advisory Panel for Outreach and
Education (APOE) (the Panel) is
governed by the provisions of the
Federal Advisory Committee Act
(FACA) (Pub. L. 92–463), as amended (5
VerDate Sep<11>2014
17:33 Jun 10, 2020
Jkt 250001
U.S.C. Appendix 2), which sets forth
standards for the formation and use of
federal advisory committees. The Panel
is authorized by section 1114(f) of the
Social Security Act (42 U.S.C. 1314(f))
and section 222 of the Public Health
Service Act (42 U.S.C. 217a).
The Secretary of the U.S. Department
of Health and Human Services (HHS)
(the Secretary) signed the charter
establishing the Citizen’s Advisory
Panel on Medicare Education 1 (the
predecessor to the APOE) on January 21,
1999 (64 FR 7899) to advise and make
recommendations to the Secretary and
the Administrator of the Centers for
Medicare & Medicaid Services (CMS) on
the effective implementation of national
Medicare education programs, including
with respect to the Medicare+Choice
(M+C) program added by the Balanced
Budget Act of 1997 (Pub. L. 105–33).
The Medicare Prescription Drug,
Improvement, and Modernization Act of
2003 (MMA) (Pub. L. 108–173)
expanded the existing health plan
options and benefits available under the
M+C program and renamed it the
Medicare Advantage (MA) program.
CMS has had substantial responsibilities
to provide information to Medicare
beneficiaries about the range of health
plan options available and better tools
to evaluate these options. The
successful MA program implementation
required CMS to consider the views and
policy input from a variety of private
sector constituents and to develop a
broad range of public-private
partnerships.
In addition, Title I of the MMA
authorized the Secretary and the
Administrator of CMS (by delegation) to
establish the Medicare prescription drug
benefit. The drug benefit allows
beneficiaries to obtain qualified
prescription drug coverage. In order to
effectively administer the MA program
and the Medicare prescription drug
benefit, we have substantial
responsibilities to provide information
to Medicare beneficiaries about the
range of health plan options and
benefits available, and to develop better
tools to evaluate these plans and
benefits.
The Patient Protection and Affordable
Care Act (Pub. L. 111–148) and Health
Care and Education Reconciliation Act
of 2010 (Pub. L. 111–152) (collectively
referred to as the Affordable Care Act)
expanded the availability of other
options for health care coverage and
enacted a number of changes to
1 We note that the Citizen’s Advisory Panel on
Medicare Education is also referred to as the
Advisory Panel on Medicare Education (65 FR
4617). The name was updated in the Second
Amended Charter approved on July 24, 2000.
PO 00000
Frm 00024
Fmt 4703
Sfmt 4703
Medicare as well as to Medicaid and
CHIP. Qualified individuals and
qualified employers are now able to
purchase private health insurance
coverage through a competitive
marketplace, called an Affordable
Insurance Exchange (also called Health
Insurance Marketplace®, or
Marketplace® 2). In order to effectively
implement and administer these
changes, we must provide information
to consumers, providers, and other
stakeholders through education and
outreach programs regarding how
existing programs will change and the
expanded range of health coverage
options available, including private
health insurance coverage through the
Marketplace®. The APOE (the Panel)
allows us to consider a broad range of
views and information from interested
audiences in connection with this effort
and to identify opportunities to enhance
the effectiveness of education strategies
concerning the Affordable Care Act.
The scope of this Panel also includes
advising on issues pertaining to the
education of providers and stakeholders
with respect to the Affordable Care Act
and certain provisions of the Health
Information Technology for Economic
and Clinical Health (HITECH) Act
enacted as part of the American
Recovery and Reinvestment Act of 2009
(ARRA) (Pub. L. 111–5).
On January 21, 2011, the Panel’s
charter was renewed and the Panel was
renamed the Advisory Panel for
Outreach and Education. The Panel’s
charter was most recently renewed on
January 19, 2019, and will terminate on
January 19, 2021 unless renewed by
appropriate action.
B. Charter Renewal
In accordance with the January 19,
2019, charter, the APOE will advise the
HHS and CMS on developing and
implementing education programs that
support individuals who are enrolled in
or eligible for Medicare, Medicaid,
CHIP, or coverage available through the
Health Insurance Marketplace® and
other CMS programs. The scope of this
Federal Advisory Committee Act
(FACA) group also includes advising on
education of providers and stakeholders
with respect to health care reform and
certain provisions of the HITECH Act
enacted as part of the ARRA.
The charter will terminate on January
19, 2021, unless renewed by appropriate
action. The APOE was chartered under
42 U.S.C. 217a, section 222 of the Public
Health Service Act, as amended. The
2 Health Insurance Marketplace® and
Marketplace® 2 are trademarks of the U.S.
Department of Health & Human Services.
E:\FR\FM\11JNN1.SGM
11JNN1
jbell on DSKJLSW7X2PROD with NOTICES
Federal Register / Vol. 85, No. 113 / Thursday, June 11, 2020 / Notices
APOE is governed by provisions of
Pubic Law 92–463, as amended (5
U.S.C. Appendix 2), which sets forth
standards for the formation and use of
advisory committees.
In accordance with the renewed
charter, the APOE will advise the
Secretary of Health and Human Services
and the CMS Administrator concerning
optimal strategies for the following:
• Developing and implementing
education and outreach programs for
individuals enrolled in, or eligible for,
Medicare, Medicaid, the CHIP, and
coverage available through the Health
Insurance Marketplace® and other CMS
programs.
• Enhancing the federal government’s
effectiveness in informing Medicare,
Medicaid, CHIP, or the Health Insurance
Marketplace® consumers, issuers,
providers, and stakeholders, pursuant to
education and outreach programs of
issues regarding these programs,
including the appropriate use of publicprivate partnerships to leverage the
resources of the private sector in
educating beneficiaries, providers,
partners and stakeholders.
• Expanding outreach to vulnerable
and underserved communities,
including racial and ethnic minorities,
in the context of Medicare, Medicaid,
the CHIP and the Health Insurance
Marketplace® education programs, and
other CMS programs as designated.
• Assembling and sharing an
information base of ‘‘best practices’’ for
helping consumers evaluate health
coverage options.
• Building and leveraging existing
community infrastructures for
information, counseling, and assistance.
• Drawing the program link between
outreach and education, promoting
consumer understanding of health care
coverage choices, and facilitating
consumer selection/enrollment, which
in turn support the overarching goal of
improved access to quality care,
including prevention services,
envisioned under the Affordable Care
Act.
The current members of the Panel as
of February 28, 2020 are: E. Lorraine
Bell, Chief Officer, Population Health,
Catholic Charities USA; Nazleen
Bharmal, Medical Director of
Community Partnerships, Cleveland
Clinic; Angie Boddie, Director of Health
Programs, National Caucus and Center
on Black Aging, Inc.; Julie Carter, Senior
Federal Policy Associate, Medicare
Rights Center; Scott Ferguson, Director
of Care Transitions and Population
Health, Mount Sinai St. Luke’s Hospital;
Leslie Fried, Senior Director, Center for
Benefits Access, National Council on
Aging; David Goldberg, President and
VerDate Sep<11>2014
17:33 Jun 10, 2020
Jkt 250001
CEO of Mon Health System; JeanVenable Robertson Goode, Professor,
Department of Pharmacotherapy and
Outcomes Science, School of Pharmacy,
Virginia Commonwealth University;
Ted Henson, Director of Health Center
Performance and Innovation, National
Association of Community Health
Centers; Joan Ilardo, Director of
Research Initiatives, Michigan State
University, College of Human Medicine;
Cheri Lattimer, Executive Director,
National Transitions of Care Coalition;
Cori McMahon, Vice President,
Tridiuum; Alan Meade, Director of
Rehab Services, Holston Medical group;
Michael Minor, National Director,
H.O.P.E. HHS Partnership, National
Baptist Convention USA, Incorporated;
Jina Ragland, Associate State Director of
Advocacy and Outreach, AARP
Nebraska; Morgan Reed, Executive
Director, Association for Competitive
Technology; Margot Savoy, Chair,
Department of Family and Community
Medicine, Temple University
Physicians; Congresswoman Allyson
Schwartz, President and CEO, Better
Medicare Alliance; and; Tia Whitaker,
Statewide Director, Outreach and
Enrollment, Pennsylvania Association
of Community Health Centers.
II. Provisions of This Notice
In accordance with section 10(a) of
the FACA, this notice announces a
meeting of the APOE. The agenda for
the June 25, 2020 meeting will include
the following:
• Welcome and listening session with
CMS leadership
• Recap of the previous (January 15,
2020) meeting
• CMS programs, initiatives, and
priorities
• An opportunity for public comment
• Meeting summary, review of
recommendations, and next steps
Individuals or organizations that wish
to make a 5-minute oral presentation on
an agenda topic should submit a written
copy of the oral presentation to the DFO
at the address listed in the ADDRESSES
section of this notice by the date listed
in the DATES section of this notice. The
number of oral presentations may be
limited by the time available.
Individuals not wishing to make an oral
presentation may submit written
comments to the DFO at the address
listed in the ADDRESSES section of this
notice by the date listed in the DATES
section of this notice.
III. Meeting Participation
This meeting will be held virtually. It
is open to the public, but attendance is
limited to registered participants.
PO 00000
Frm 00025
Fmt 4703
Sfmt 4703
35657
Persons wishing to attend this meeting
must register by contacting the DFO at
the address listed in the ADDRESSES
section of this notice or by telephone at
the number listed in the FOR FURTHER
INFORMATION CONTACT section of this
notice by the date specified in the DATES
section of this notice.
IV. Collection of Information
This document does not impose
information collection requirements,
that is, reporting, recordkeeping, or
third-party disclosure requirements.
Consequently, there is no need for
review by the Office of Management and
Budget under the authority of the
Paperwork Reduction Act of 1995 (44
U.S.C. Chapter 35).
The Administrator of the Centers for
Medicare & Medicaid Services (CMS),
Seema Verma, having reviewed and
approved this document, authorizes
Evell J. Barco Holland, who is the
Federal Register Liaison, to
electronically sign this document for
purposes of publication in the Federal
Register.
Authority: Sec. 1114(f) of the Social
Security Act (42 U.S.C. 1314(f)), sec. 222 of
the Public Health Service Act (42 U.S.C.
217a), and sec. 10(a) of Pub. L. 92–463 (5
U.S.C. App. 2, sec. 10(a) and 41 CFR part
102–3).
Dated: June 4, 2020.
Evell J. Barco Holland,
Federal Register Liaison, Department of
Health and Human Services.
[FR Doc. 2020–12653 Filed 6–10–20; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
E:\FR\FM\11JNN1.SGM
11JNN1
]]>Agencies
[Federal Register Volume 85, Number 113 (Thursday, June 11, 2020)]
[Notices]
[Pages 35655-35657]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-12653]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-7058-N]
Announcement of the Advisory Panel on Outreach and Education
(APOE) June 25, 2020 Meeting
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces the next meeting of the APOE (the Panel)
in accordance with the Federal Advisory Committee Act. The Panel
advises and makes recommendations to the Secretary of the U.S.
Department of Health and Human Services (HHS) and the Administrator of
the Centers for Medicare & Medicaid Services (CMS) on opportunities to
enhance the
[[Page 35656]]
effectiveness of consumer education strategies concerning the Health
Insurance Marketplace, Medicare, Medicaid, and the Children's Health
Insurance Program (CHIP). This meeting is open to the public.
DATES:
Meeting Date: Thursday, June 25, 2020, 12:30 p.m. to 4:45 p.m.
eastern daylight time (e.d.t).
Deadline for Meeting Registration, Presentations, Special
Accommodations and Comments: Wednesday, June 17, 2020, 5:00 p.m.
eastern daylight time (e.d.t).
ADDRESSES:
Meeting Location: The meeting will be held virtually. All those who
RSVP will receive the link to attend.
Presentations and Written Comments: Presentations and written
comments should be submitted to: Lisa Carr, Designated Federal Official
(DFO), Office of Communications, Centers for Medicare & Medicaid
Services, 200 Independence Avenue SW, Mailstop 325G HHH, Washington, DC
20201, 202-690-5742, or via email at [email protected].
Registration: The meeting is open to the public, but attendance is
limited to the space available. Persons wishing to attend this meeting
must register at the website https://www.eventbrite.com/e/104529556718/
or by contacting the DFO listed in the FOR FURTHER INFORMATION CONTACT
section of this notice, by the date listed in the DATES section of this
notice. Individuals requiring sign language interpretation or other
special accommodations should contact the DFO at the address listed in
the ADDRESSES section of this notice by the date listed in the DATES
section of this notice.
FOR FURTHER INFORMATION CONTACT: Lisa Carr, Designated Federal
Official, Office of Communications, 200 Independence Avenue SW,
Mailstop 325G HHH, Washington, DC 20201, 202-690-5742, or via email at
[email protected]. Additional information about the APOE is available
at: https://www.cms.gov/Regulations-and-Guidance/Guidance/FACA/APOE.
Press inquiries are handled through the CMS Press Office at (202) 690-
6145.
SUPPLEMENTARY INFORMATION:
I. Background and Charter Renewal Information
A. Background
The Advisory Panel for Outreach and Education (APOE) (the Panel) is
governed by the provisions of the Federal Advisory Committee Act (FACA)
(Pub. L. 92-463), as amended (5 U.S.C. Appendix 2), which sets forth
standards for the formation and use of federal advisory committees. The
Panel is authorized by section 1114(f) of the Social Security Act (42
U.S.C. 1314(f)) and section 222 of the Public Health Service Act (42
U.S.C. 217a).
The Secretary of the U.S. Department of Health and Human Services
(HHS) (the Secretary) signed the charter establishing the Citizen's
Advisory Panel on Medicare Education \1\ (the predecessor to the APOE)
on January 21, 1999 (64 FR 7899) to advise and make recommendations to
the Secretary and the Administrator of the Centers for Medicare &
Medicaid Services (CMS) on the effective implementation of national
Medicare education programs, including with respect to the
Medicare+Choice (M+C) program added by the Balanced Budget Act of 1997
(Pub. L. 105-33).
---------------------------------------------------------------------------
\1\ We note that the Citizen's Advisory Panel on Medicare
Education is also referred to as the Advisory Panel on Medicare
Education (65 FR 4617). The name was updated in the Second Amended
Charter approved on July 24, 2000.
---------------------------------------------------------------------------
The Medicare Prescription Drug, Improvement, and Modernization Act
of 2003 (MMA) (Pub. L. 108-173) expanded the existing health plan
options and benefits available under the M+C program and renamed it the
Medicare Advantage (MA) program. CMS has had substantial
responsibilities to provide information to Medicare beneficiaries about
the range of health plan options available and better tools to evaluate
these options. The successful MA program implementation required CMS to
consider the views and policy input from a variety of private sector
constituents and to develop a broad range of public-private
partnerships.
In addition, Title I of the MMA authorized the Secretary and the
Administrator of CMS (by delegation) to establish the Medicare
prescription drug benefit. The drug benefit allows beneficiaries to
obtain qualified prescription drug coverage. In order to effectively
administer the MA program and the Medicare prescription drug benefit,
we have substantial responsibilities to provide information to Medicare
beneficiaries about the range of health plan options and benefits
available, and to develop better tools to evaluate these plans and
benefits.
The Patient Protection and Affordable Care Act (Pub. L. 111-148)
and Health Care and Education Reconciliation Act of 2010 (Pub. L. 111-
152) (collectively referred to as the Affordable Care Act) expanded the
availability of other options for health care coverage and enacted a
number of changes to Medicare as well as to Medicaid and CHIP.
Qualified individuals and qualified employers are now able to purchase
private health insurance coverage through a competitive marketplace,
called an Affordable Insurance Exchange (also called Health Insurance
Marketplace[supreg], or Marketplace[supreg] \2\). In order to
effectively implement and administer these changes, we must provide
information to consumers, providers, and other stakeholders through
education and outreach programs regarding how existing programs will
change and the expanded range of health coverage options available,
including private health insurance coverage through the
Marketplace[supreg]. The APOE (the Panel) allows us to consider a broad
range of views and information from interested audiences in connection
with this effort and to identify opportunities to enhance the
effectiveness of education strategies concerning the Affordable Care
Act.
---------------------------------------------------------------------------
\2\ Health Insurance Marketplace[supreg] and Marketplace[supreg]
\2\ are trademarks of the U.S. Department of Health & Human
Services.
---------------------------------------------------------------------------
The scope of this Panel also includes advising on issues pertaining
to the education of providers and stakeholders with respect to the
Affordable Care Act and certain provisions of the Health Information
Technology for Economic and Clinical Health (HITECH) Act enacted as
part of the American Recovery and Reinvestment Act of 2009 (ARRA) (Pub.
L. 111-5).
On January 21, 2011, the Panel's charter was renewed and the Panel
was renamed the Advisory Panel for Outreach and Education. The Panel's
charter was most recently renewed on January 19, 2019, and will
terminate on January 19, 2021 unless renewed by appropriate action.
B. Charter Renewal
In accordance with the January 19, 2019, charter, the APOE will
advise the HHS and CMS on developing and implementing education
programs that support individuals who are enrolled in or eligible for
Medicare, Medicaid, CHIP, or coverage available through the Health
Insurance Marketplace[supreg] and other CMS programs. The scope of this
Federal Advisory Committee Act (FACA) group also includes advising on
education of providers and stakeholders with respect to health care
reform and certain provisions of the HITECH Act enacted as part of the
ARRA.
The charter will terminate on January 19, 2021, unless renewed by
appropriate action. The APOE was chartered under 42 U.S.C. 217a,
section 222 of the Public Health Service Act, as amended. The
[[Page 35657]]
APOE is governed by provisions of Pubic Law 92-463, as amended (5
U.S.C. Appendix 2), which sets forth standards for the formation and
use of advisory committees.
In accordance with the renewed charter, the APOE will advise the
Secretary of Health and Human Services and the CMS Administrator
concerning optimal strategies for the following:
Developing and implementing education and outreach
programs for individuals enrolled in, or eligible for, Medicare,
Medicaid, the CHIP, and coverage available through the Health Insurance
Marketplace[supreg] and other CMS programs.
Enhancing the federal government's effectiveness in
informing Medicare, Medicaid, CHIP, or the Health Insurance
Marketplace[supreg] consumers, issuers, providers, and stakeholders,
pursuant to education and outreach programs of issues regarding these
programs, including the appropriate use of public-private partnerships
to leverage the resources of the private sector in educating
beneficiaries, providers, partners and stakeholders.
Expanding outreach to vulnerable and underserved
communities, including racial and ethnic minorities, in the context of
Medicare, Medicaid, the CHIP and the Health Insurance
Marketplace[supreg] education programs, and other CMS programs as
designated.
Assembling and sharing an information base of ``best
practices'' for helping consumers evaluate health coverage options.
Building and leveraging existing community infrastructures
for information, counseling, and assistance.
Drawing the program link between outreach and education,
promoting consumer understanding of health care coverage choices, and
facilitating consumer selection/enrollment, which in turn support the
overarching goal of improved access to quality care, including
prevention services, envisioned under the Affordable Care Act.
The current members of the Panel as of February 28, 2020 are: E.
Lorraine Bell, Chief Officer, Population Health, Catholic Charities
USA; Nazleen Bharmal, Medical Director of Community Partnerships,
Cleveland Clinic; Angie Boddie, Director of Health Programs, National
Caucus and Center on Black Aging, Inc.; Julie Carter, Senior Federal
Policy Associate, Medicare Rights Center; Scott Ferguson, Director of
Care Transitions and Population Health, Mount Sinai St. Luke's
Hospital; Leslie Fried, Senior Director, Center for Benefits Access,
National Council on Aging; David Goldberg, President and CEO of Mon
Health System; Jean-Venable Robertson Goode, Professor, Department of
Pharmacotherapy and Outcomes Science, School of Pharmacy, Virginia
Commonwealth University; Ted Henson, Director of Health Center
Performance and Innovation, National Association of Community Health
Centers; Joan Ilardo, Director of Research Initiatives, Michigan State
University, College of Human Medicine; Cheri Lattimer, Executive
Director, National Transitions of Care Coalition; Cori McMahon, Vice
President, Tridiuum; Alan Meade, Director of Rehab Services, Holston
Medical group; Michael Minor, National Director, H.O.P.E. HHS
Partnership, National Baptist Convention USA, Incorporated; Jina
Ragland, Associate State Director of Advocacy and Outreach, AARP
Nebraska; Morgan Reed, Executive Director, Association for Competitive
Technology; Margot Savoy, Chair, Department of Family and Community
Medicine, Temple University Physicians; Congresswoman Allyson Schwartz,
President and CEO, Better Medicare Alliance; and; Tia Whitaker,
Statewide Director, Outreach and Enrollment, Pennsylvania Association
of Community Health Centers.
II. Provisions of This Notice
In accordance with section 10(a) of the FACA, this notice announces
a meeting of the APOE. The agenda for the June 25, 2020 meeting will
include the following:
Welcome and listening session with CMS leadership
Recap of the previous (January 15, 2020) meeting
CMS programs, initiatives, and priorities
An opportunity for public comment
Meeting summary, review of recommendations, and next steps
Individuals or organizations that wish to make a 5-minute oral
presentation on an agenda topic should submit a written copy of the
oral presentation to the DFO at the address listed in the ADDRESSES
section of this notice by the date listed in the DATES section of this
notice. The number of oral presentations may be limited by the time
available. Individuals not wishing to make an oral presentation may
submit written comments to the DFO at the address listed in the
ADDRESSES section of this notice by the date listed in the DATES
section of this notice.
III. Meeting Participation
This meeting will be held virtually. It is open to the public, but
attendance is limited to registered participants. Persons wishing to
attend this meeting must register by contacting the DFO at the address
listed in the ADDRESSES section of this notice or by telephone at the
number listed in the FOR FURTHER INFORMATION CONTACT section of this
notice by the date specified in the DATES section of this notice.
IV. Collection of Information
This document does not impose information collection requirements,
that is, reporting, recordkeeping, or third-party disclosure
requirements. Consequently, there is no need for review by the Office
of Management and Budget under the authority of the Paperwork Reduction
Act of 1995 (44 U.S.C. Chapter 35).
The Administrator of the Centers for Medicare & Medicaid Services
(CMS), Seema Verma, having reviewed and approved this document,
authorizes Evell J. Barco Holland, who is the Federal Register Liaison,
to electronically sign this document for purposes of publication in the
Federal Register.
Authority: Sec. 1114(f) of the Social Security Act (42 U.S.C.
1314(f)), sec. 222 of the Public Health Service Act (42 U.S.C.
217a), and sec. 10(a) of Pub. L. 92-463 (5 U.S.C. App. 2, sec. 10(a)
and 41 CFR part 102-3).
Dated: June 4, 2020.
Evell J. Barco Holland,
Federal Register Liaison, Department of Health and Human Services.
[FR Doc. 2020-12653 Filed 6-10-20; 8:45 am]
BILLING CODE 4120-01-P
